Pancreatic islet transplantation remains an experimental therapy for patients with type 1 diabetes, but studies continue to show promising results. Sunday afternoon during the Joint ADA/Diabetes UK Symposium, four researchers will offer a snapshot of where islet transplantation stands today and offer perspective on what must happen in the future to advance the therapy. Andrew M. Posselt, MD, PhD, will chair the symposium.

Read More